Literature DB >> 20795770

Causes for hospitalization and death in Iranian patients with β-thalassemia major.

Masood Bazrgar1, Farah Peiravian, Fatemeh Abedpour, Mehran Karimi.   

Abstract

There are limited studies that have focused on the causes for hospitalization as an indicator of morbidity in patients with β-thalassemia major (BTM). A cross-sectional study was conducted to determine the main causes for hospitalization and death in hospitalized BTM patients in a referral hospital in Shiraz, southern Iran. During a 5-year period, 555 BTM patients were admitted to the hospital, of which 390 (67.7%) were 10 to 20 years of age. The most frequent causes for hospitalization were splenectomy (23%), heart failure (22.6%), liver biopsy (22.2%), uncontrolled diabetes (10.9%), arrhythmia (7.2%), cholecystectomy (3.8%), hypoparathyroidism (2.1%), and sepsis (2%). Of the hospitalized patients, 65 (11%), with a mean age of 16.1 ± 4.2 years, died. The most common causes of death were cardiomyopathy (72.3%), infections (17%), malignancies (3.1%), and cerebrovascular accidents (3.1%). Survival of our patients was less than in developed countries and cardiac complications were the most common cause of mortality and morbidity in these patients. Regarding the key role of iron chelation in prevention of different complications in BTM, correction of iron chelation regimen should be well considered.

Entities:  

Mesh:

Year:  2010        PMID: 20795770     DOI: 10.3109/08880018.2010.503336

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  8 in total

1.  Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.

Authors:  Khalid Al-Naamani; Ibrahim Al-Zakwani; Siham Al-Sinani; Fauzia Wasim; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

2.  Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.

Authors:  Ali Bazi; Javad Sharifi-Rad; Daryoush Rostami; Omolbanin Sargazi-Aval; Amin Safa
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Negative affect differentiation and adherence during treatment for thalassemia.

Authors:  Karin G Coifman; Gail S Ross; Dorothy Kleinert; Patricia Giardina
Journal:  Int J Behav Med       Date:  2014-02

4.  Major causes of hospital admission in Beta thalassemia major patients in southern iran.

Authors:  Mehran Karimi; Vahid Emadmarvasti; Jacob Hoseini; Lotfolah Shoja
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

Review 5.  Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis.

Authors:  Li-Na He; Wei Chen; Yi Yang; Ying-Jun Xie; Ze-Yu Xiong; Di-Yu Chen; Dian Lu; Neng-Qing Liu; Ying-Hong Yang; Xiao-Fang Sun
Journal:  Biomed Res Int       Date:  2019-04-18       Impact factor: 3.411

6.  Experience of Uncertainty in Patients with Thalassemia Major: A Qualitative Study.

Authors:  Mehrnaz Ahmadi; Mahin Gheibizadeh; Maryam Rassouli; Abbas Ebadi; Marziyeh Asadizaker; Mojtaba Jahanifar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

7.  Evaluation and cost analysis of national health policy of thalassaemia screening in west-azerbaijan province of iran.

Authors:  Elham Ahmadnezhad; Nariman Sepehrvand; Farshid Fayyaz Jahani; Sanaz Hatami; Catauon Kargar; Majid Mirmohammadkhani; Shahrzad Bazargan-Hejazi
Journal:  Int J Prev Med       Date:  2012-10

8.  The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran.

Authors:  Alireza Ansari-Moghaddam; Hossein Ali Adineh; Iraj Zareban; Mehdi Mohammadi; Mahtab Maghsoodlu
Journal:  Epidemiol Health       Date:  2018-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.